Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockGet instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Fabino Enterprises Limited is primarily engaged in the manufacturing and marketing of pharmaceutical, allopathic, herbal, and veterinary products under its own brand names, targeting both domestic and international markets.
Fabino's operations include a manufacturing plant in Sonipat, Haryana, and it markets over 70 products in the domestic market, along with a diverse portfolio of FMCG products for international markets.
The company has achieved ISO 9001:2015 certification, reflecting its commitment to high-quality standards in manufacturing processes and quality management systems.
Fabino Enterprises has expanded its scope to include agriculture-related products and activities, as well as food processing and exports, highlighting a strategic diversification into the agriculture sector.
The company IPO in January 2022 reflected strategic growth initiatives, raising funds to diversify its operations with a focus on FMCG and wellness sectors.
Pharmaceuticals & Biotechnology
Pharmaceuticals
4 Cr
Low Risk
-7.6
34.1
—
1.2
38.96
13.01
Sales CAGR
Profit CAGR
ROE
ROCE
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Fabino Enterprises Ltd (FABINO) is currently trading at N/A per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Fabino Enterprises Limited is primarily engaged in the manufacturing and marketing of pharmaceutical, allopathic, herbal, and veterinary products under its own brand names, targeting both domestic and international markets. Fabino's operations include a manufacturing plant in Sonipat, Haryana, and it markets over 70 products in the domestic market, along with a diverse portfolio of FMCG products for international markets. The company has achieved ISO 9001:2015 certification, reflecting its commitment to high-quality standards in manufacturing processes and quality management systems. Fabino Enterprises has expanded its scope to include agriculture-related products and activities, as well as food processing and exports, highlighting a strategic diversification into the agriculture sector. The company IPO in January 2022 reflected strategic growth initiatives, raising funds to diversify its operations with a focus on FMCG and wellness sectors.
Over the past 52 weeks, Fabino Enterprises Ltd has traded between a low of ₹13.01 and a high of ₹38.96. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Fabino Enterprises Ltd has a market capitalization of approximately 4.27. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Fabino Enterprises Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -7.62 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 4.27 Cr, Fabino Enterprises Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Fabino Enterprises Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Fabino Enterprises Ltd is -7.62. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bearish
7
Neutral
3
Bullish
4
Bearish
7
Neutral
19
Bullish
20
Bearish
0
Neutral
16
Bullish
16
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
1.86 | 8 Cr | 19.20 | 1.76 | 0.00 | 9.05 | 5.66 | 1.81 | ||
58.25 | 7 Cr | 14.39 | 0.84 | 0.00 | 5.12 | 7.05 | 3.99 | ||
12.00 | 7 Cr | 70.90 | 0.85 | 0.00 | 1.22 | 2.79 | 1.04 | ||
6.23 | 6 Cr | -1.42 | 0.30 | 0.00 | -14.93 | -17.41 | -17.71 | ||
19.00 | 6 Cr | -5.59 | 1.90 | 0.00 | — | — | 0.00 | ||
5.29 | 5 Cr | 44.33 | 0.52 | 0.00 | 1.11 | 1.49 | 1.16 | ||
20.31 | 4 Cr | -7.62 | 1.17 | 0.00 | -15.32 | -11.50 | -2.53 | ||
| Median: 7 Co. | — | 12.00 | 6 Cr | 14.39 | 0.85 | 0.00 | 1.17 | 2.14 | 1.04 |
